Affinity Asset Advisors »

Sagimet Biosciences Inc-a shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4M 350k 6.86

More positions owned by Affinity Asset Advisors

Insmed Com Par $.01 (INSM)
Verona Pharma Sponsored Ads (VRNA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Merus N V (MRUS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Lexeo Therapeutics (LXEO)

View all positions for Affinity Asset Advisors

Top funds holding Sagimet Biosciences Inc-a

Woodline Partners
Blue Owl Capital Holdings
Vanguard Group
Baker Bros. Advisors
Millennium Management
Hillhouse Capital Advisors
Siren
D. E. Shaw & Co
BlackRock
Schonfeld Strategic Advisors
Affinity Asset Advisors
Readystate Asset Management
UBS Group
Bridgeway Capital Management
Geode Capital Management

View all funds holding Sagimet Biosciences Inc-a